These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27425386)

  • 1. Expression of Markers of Hepatocellular Differentiation in Pancreatic Acinar Cell Neoplasms:  A Potential Diagnostic Pitfall.
    Askan G; Deshpande V; Klimstra DS; Adsay V; Sigel C; Shia J; Basturk O
    Am J Clin Pathol; 2016 Aug; 146(2):163-9. PubMed ID: 27425386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms.
    Shahid M; Mubeen A; Tse J; Kakar S; Bateman AC; Borger D; Rivera MN; Ting DT; Deshpande V
    Am J Surg Pathol; 2015 Jan; 39(1):25-34. PubMed ID: 25353287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginase-1: a highly specific marker separating pancreatic adenocarcinoma from hepatocellular carcinoma.
    Fatima N; Cohen C; Siddiqui MT
    Acta Cytol; 2014; 58(1):83-8. PubMed ID: 24281232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of arginase-1, glypican-3, hepatocyte paraffin antigen 1 and alpha-fetoprotein in diagnosis and differential diagnosis of liver tumors].
    Li J; Wei L
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):246-50. PubMed ID: 24915815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginase-1 is a more sensitive marker of hepatic differentiation than HepPar-1 and glypican-3 in fine-needle aspiration biopsies.
    Fujiwara M; Kwok S; Yano H; Pai RK
    Cancer Cytopathol; 2012 Aug; 120(4):230-7. PubMed ID: 22434791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arginase-1, HepPar-1, and Glypican-3 are the most effective panel of markers in distinguishing hepatocellular carcinoma from metastatic tumor on fine-needle aspiration specimens.
    Timek DT; Shi J; Liu H; Lin F
    Am J Clin Pathol; 2012 Aug; 138(2):203-10. PubMed ID: 22904131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 5 Immunohistochemical Markers of Hepatocellular Differentiation for the Diagnosis of Hepatocellular Carcinoma.
    Nguyen T; Phillips D; Jain D; Torbenson M; Wu TT; Yeh MM; Kakar S
    Arch Pathol Lab Med; 2015 Aug; 139(8):1028-34. PubMed ID: 26230595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large acinar cell carcinoma of the pancreas in a patient with elevated serum AFP level.
    Eriguchi N; Aoyagi S; Hara M; Okuda K; Saito N; Fukuda S; Akashi H; Kutami R; Jimi A
    J Hepatobiliary Pancreat Surg; 2000; 7(2):222-5. PubMed ID: 10982618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Huge pancreatic acinar cell carcinoma with high levels of AFP and fucosylated AFP (AFP-L3).
    Hiraoka A; Nakahara H; Kawasaki H; Shimizu Y; Hidaka S; Imai Y; Utsunomiya H; Tatsukawa H; Tazuya N; Yamago H; Yorimitsu N; Tanihira T; Hasebe A; Miyamoto Y; Ninomiya T; Abe M; Hiasa Y; Matsuura B; Onji M; Michitaka K
    Intern Med; 2012; 51(11):1341-9. PubMed ID: 22687839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboxypeptidase A1 and regenerating islet-derived 1α as new markers for pancreatic acinar cell carcinoma.
    Said S; Kurtin PJ; Nasr SH; Graham RP; Dasari S; Vrana JA; Yasir S; Torbenson MS; Zhang L; Mounajjed T; Eric Chen ZM; Lee HE; Wu TT
    Hum Pathol; 2020 Sep; 103():120-126. PubMed ID: 32702400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The strength of cytomorphology and efficacy of immuno-cytochemistry in distinguishing hepatocellular carcinoma from its mimics on fine-needle aspiration cytology.
    Chikhale M; Toi PC; Siddaraju N; Ananthakrishnan R
    Diagn Cytopathol; 2021 Jul; 49(7):864-875. PubMed ID: 33929782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginase-1 is frequently positive in hepatoid adenocarcinomas.
    Chandan VS; Shah SS; Torbenson MS; Wu TT
    Hum Pathol; 2016 Sep; 55():11-6. PubMed ID: 27137985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte differentiation markers in adenocarcinoma of the prostate: hepatocyte paraffin 1 but not arginase-1 is specifically expressed in a subset of prostatic adenocarcinoma.
    Giedl J; Büttner-Herold M; Wach S; Wullich B; Hartmann A; Agaimy A
    Hum Pathol; 2016 Sep; 55():101-7. PubMed ID: 27184483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
    Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
    Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal-type gastrointestinal adenocarcinoma: a morphologically distinct entity with unfavourable prognosis.
    Arora K; Bal M; Shih A; Moy A; Zukerberg L; Brown I; Liu X; Kelly P; Oliva E; Mullen J; Ahn S; Kim KM; Deshpande V
    J Clin Pathol; 2018 Mar; 71(3):221-227. PubMed ID: 28814568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCL10 as a useful marker for pancreatic acinar cell carcinoma, especially using endoscopic ultrasound cytology specimens.
    Hosoda W; Sasaki E; Murakami Y; Yamao K; Shimizu Y; Yatabe Y
    Pathol Int; 2013 Mar; 63(3):176-82. PubMed ID: 23530562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms.
    Yan BC; Gong C; Song J; Krausz T; Tretiakova M; Hyjek E; Al-Ahmadie H; Alves V; Xiao SY; Anders RA; Hart JA
    Am J Surg Pathol; 2010 Aug; 34(8):1147-54. PubMed ID: 20661013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginase-1: a novel immunohistochemical marker of hepatocellular differentiation in fine needle aspiration cytology.
    McKnight R; Nassar A; Cohen C; Siddiqui MT
    Cancer Cytopathol; 2012 Aug; 120(4):223-9. PubMed ID: 22298472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginase-1 is a more sensitive marker than HepPar-1 and AFP in differential diagnosis of hepatocellular carcinoma from nonhepatocellular carcinoma.
    Sang W; Zhang W; Cui W; Li X; Abulajiang G; Li Q
    Tumour Biol; 2015 May; 36(5):3881-6. PubMed ID: 25577247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical Study of Glypican-3 and HepPar-1 in Differentiating Hepatocellular Carcinoma from Metastatic Carcinomas in FNA of the Liver.
    Ibrahim TR; Abdel-Raouf SM
    Pathol Oncol Res; 2015 Apr; 21(2):379-87. PubMed ID: 25108409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.